Goker E, Hendriks MP, van Tilburg M, Barcaru A, et al. Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions. Eur J Cancer 2022;167:92-102.
PMID: 35421703